Hepatitis B Vaccine as a Primary Prevention Strategy for Cancer: Mechanisms, Outcomes and Model Extension

Vaccination against Hepatitis B can prevent liver cancer by preventing chronic infection of the liver. This paper reviews the role of hepatitis B virus (HBV) in hepatocellular carcinoma, cancer prevention via vaccination, and lessons learned from China's experience for other cancer-prevention programmes. HBV promotes cancer by inducing chronic inflammation in the host, integrating viral DNA into the host's DNA, and altering cell regulation through viral proteins. China's childhood vaccination programme has reduced infections among young children significantly. Extended data from the Qidong trial have also indicated a decrease in primary liver cancer; however, due to a small number of cancer cases, the exact extent remains unknown. Comparison with human papillomavirus (HPV) vaccination shows that the biological principle can be applied to infections, but delivery needs to match the age and circumstances of the target population. China's addition of HPV vaccination to the national programme in 2025 is a policy change. Disease spread can be effectively prevented through timely vaccination, accessible medical services, and ongoing care for high-risk groups.

Authors

Institutions

Publication Details

Journal
Theoretical and Natural Science
Published
2026-11-17
DOI
https://doi.org/10.54254/2753-8818/2027.mb39186
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hepatitis B Vaccine as a Primary Prevention Strategy for Cancer: Mechanisms, Outcomes and Model Extension

Qingyang Xia
Theoretical and Natural Science
Hepatitis B Virus Studies
article

Hepatitis B Vaccine as a Primary Prevention Strategy for Cancer: Mechanisms, Outcomes and Model Extension

Qingyang Xia
article en

Abstract

Vaccination against Hepatitis B can prevent liver cancer by preventing chronic infection of the liver. This paper reviews the role of hepatitis B virus (HBV) in hepatocellular carcinoma, cancer prevention via vaccination, and lessons learned from China's experience for other cancer-prevention programmes. HBV promotes cancer by inducing chronic inflammation in the host, integrating viral DNA into the host's DNA, and altering cell regulation through viral proteins. China's childhood vaccination programme has reduced infections among young children significantly. Extended data from the Qidong trial have also indicated a decrease in primary liver cancer; however, due to a small number of cancer cases, the exact extent remains unknown. Comparison with human papillomavirus (HPV) vaccination shows that the biological principle can be applied to infections, but delivery needs to match the age and circumstances of the target population. China's addition of HPV vaccination to the national programme in 2025 is a policy change. Disease spread can be effectively prevented through timely vaccination, accessible medical services, and ongoing care for high-risk groups.

Theoretical and Natural ScienceVol. 202(1)
Rainwater Charitable Foundation (US)
Good health and well-being
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon